Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuta Tomida

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Molecular Cancer|June 3, 2014
Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancerYosuke Togashi, Hiroki Sakamoto, Hidetoshi Hayashi, et al.
Cancer Letters|December 3, 2014
Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancerYosuke Togashi, Akihiro Kogita, Hiroki Sakamoto, et al.
Odontology|May 21, 2020
Microbiome composition comparison in oral and atherosclerotic plaque from patients with and without periodontitisDaichi Isoshima, Keisuke Yamashiro, Kazuyuki Matsunaga, et al.
The Journal of Clinical Investigation|March 10, 2026
Spatial single-cell proteotyping reveals immunotherapy-resistant features within the complex tumor microenvironment of metastatic NSCLCKohsuke Isomoto, Koji Haratani, Takahiro Tsujikawa, et al.
Cancer Science|June 5, 2019
Acquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cellsTakahiro Yoshioka, Kazuhiko Shien, Tatsuaki Takeda, et al.
International Journal of Oncology|December 16, 2014
Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancerAkihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, et al.
International Journal of Oncology|August 7, 2014
Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transitionAkihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, et al.
Journal of Thoracic Disease|December 10, 2017
Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancerHidejiro Torigoe, Junichi Soh, Shuta Tomida, et al.
Scientific Reports|June 1, 2023
Identification of genetic loci associated with renal dysfunction after lung transplantation using an ethnic-specific single-nucleotide polymorphism arrayYasuaki Tomioka, Seiichiro Sugimoto, Haruchika Yamamoto, et al.
International Journal of Cancer|June 21, 2021
Oncogenic potential of human pluripotent stem cell-derived lung organoids with HER2 overexpressionAkihiro Miura, Daisuke Yamada, Masahiro Nakamura, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Molecular Cancer|June 3, 2014
Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancerYosuke Togashi, Hiroki Sakamoto, Hidetoshi Hayashi, et al.
Cancer Letters|December 3, 2014
Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancerYosuke Togashi, Akihiro Kogita, Hiroki Sakamoto, et al.
Odontology|May 21, 2020
Microbiome composition comparison in oral and atherosclerotic plaque from patients with and without periodontitisDaichi Isoshima, Keisuke Yamashiro, Kazuyuki Matsunaga, et al.
The Journal of Clinical Investigation|March 10, 2026
Spatial single-cell proteotyping reveals immunotherapy-resistant features within the complex tumor microenvironment of metastatic NSCLCKohsuke Isomoto, Koji Haratani, Takahiro Tsujikawa, et al.
Cancer Science|June 5, 2019
Acquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cellsTakahiro Yoshioka, Kazuhiko Shien, Tatsuaki Takeda, et al.
International Journal of Oncology|December 16, 2014
Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancerAkihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, et al.
International Journal of Oncology|August 7, 2014
Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transitionAkihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, et al.
Journal of Thoracic Disease|December 10, 2017
Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancerHidejiro Torigoe, Junichi Soh, Shuta Tomida, et al.
Scientific Reports|June 1, 2023
Identification of genetic loci associated with renal dysfunction after lung transplantation using an ethnic-specific single-nucleotide polymorphism arrayYasuaki Tomioka, Seiichiro Sugimoto, Haruchika Yamamoto, et al.
International Journal of Cancer|June 21, 2021
Oncogenic potential of human pluripotent stem cell-derived lung organoids with HER2 overexpressionAkihiro Miura, Daisuke Yamada, Masahiro Nakamura, et al.
Pageof 17